Post mortem studies of psychiatric disorders have been revitalised by several developments. Molecular biology has provided tools for studying genes and their expression in post mortem brain tissue, an approach which facilitates integration of molecular genetics with neurochemistry and neuropathology.The techniques can be used quantitatively as well as qualitatively, applications which have been aided by developments in image analysis. Accompanying these advances has been an improvement in the robustness of the data as a result of greater attention to confounding variables and other methodological improvements.These issues are illustrated by two recent areas of interest in schizophrenia research: the expression of central dopamine D 4 and 5-HT receptors, and synoptic pathology.
Examining the brain has always been a cornerstone of biological psychiatry. For example, the recent profound advances in understanding of Alzheimer's disease aetiopathogenesis, although largely genetic in nature, have their roots in pathochemical studies of Alzheimer's disease brain tissue. It was from this source that the composition of amyloid plaques and neurofibrillary tangles was revealed and the central role of cholinergic deficits in producing the cognitive impairment of the disease was established. Such discoveries contributed significantly to the identification of the disease-causing genes and to potential therapeutic avenues.
Post mortem studies have played similarly important roles in other 'organic' psychiatric conditions, whereas for the 'functional' disorders, their contribution has been more modest and their status has waxed and waned. However, the post mortem approach is currently enjoying a renaissance in all areas of psychiatry. This has come about for several reasons. Firstly, greater attention is being paid to research design and execution, reducing the influence of confounding variables and increasing the ability to identify genuine differences between the groups being compared. Secondly, many molecular biological methods have proved to be suitable for post mortem research, allowing genes and gene expression to be studied in addition to the conventional neurochemical study of receptors, enzymes and so on. Thirdly, experimental approaches have converged, blurring the distinction between abnormalities of structure (neuropathology) and of function (neurochemistry).
These areas of progress are neither mutually exclusive nor exhaustive. However, they serve as a useful focus for a review of recent post mortem biological psychiatry research. The themes are developed and illustrated here with reference to aspects of schizophrenia.
New tools for old questions
The techniques of molecular biology have been adopted rapidly for use in post mortem research 1 " 3 . The ability to detect mRNA allows gene expression to be investigated and to complement studies which target the protein products. mRNA-directed techniques have several attractions: molecular probes are more specific, reducing problems of crossreactivity with related molecular species; they can be designed to detect isoforms or other mRNA variants which may be functionally important but undetectable at the protein level, and the abundance of an mRNA gives quantitative information about synthesis of the encoded protein. A range of techniques for studying mRNAs is now available for post mortem brain research; these techniques vary in their sensitivity, anatomical resolution (from single cell to whole brain) and ease of use (see 4 -5 ; Table 1 ). The ability to retrieve intact mRNA from post mortem tissue also permits techniques such as subtractive hybridization 6 and in vitro translation/two-dimensional protein electrophoresis 7 in which the repertoire of expressed genes can be investigated. In addition, the cloning and sequencing of genes, and the ability to express genes in various systems, has facilitated the development of an ever increasing range of antibodies against proteins of interest including receptors, which were previously only detectable by less specific ligands. Their availability allows individual gene products to be detected by immunoblotting 8 . These improve the potential and practicality of accurate, rapid and automated measurements. They have contributed to an increasing preference for tissue sections rather than tissue homogenates as the starting material for research, to allow measurements over identified neuronal populations. Suitable images include autoradiograms generated from radioligand receptor binding, in situ hybridization or immunoautoradiography, whilst sections can also be analysed after conventional or histochemical staining. Furthermore, expression of mRNAs can be studied in individual neurons and their environs using liquid emulsion autoradiography and grain counting 12 -13 . The options for research at this high level of anatomical resolution are further extended by confocal microscopy 14 . Neuroanatomical and neuropathological studies have also benefited from a different quantitative advance, that of stereological methods for counting cells 15 . They allow robust and biologically meaningful assessments of absolute neuronal number to be made which overcome problems associated with the traditional assessment of neuronal density (neurons per unit area or volume) 16 ; however, they do require a considerable investment of time, material and money, which may not always be necessary 17 . Taken together, these new tools greatly increase the range and power of post mortem approaches to biological psychiatry. Examples of recent applications of these techniques with regard to schizophrenia research are given later in this chapter.
Recognition of confounders and improvements in experimental design
Inherent in all post mortem studies, especially neurochemical ones, is a large brain-to-brain variability. Much of this experimental noise can be attributed to a number of confounding factors operating in the peri-mortem period. These were recognised by neurochemists in the pre-molecular days 18 , and have been rediscovered as being of equal if not greater importance for measurements of RNA and gene expression 19 . However powerful the newer methodologies may be, without adequate characterisation of these factors they are still likely to result in data of doubtful value.
Post mortem interval is usually cited as the main problem with post mortem research. Certainly for some biochemical and ultrastructural measurements it is. However, for the majority of purposes, routine post mortem intervals (at least 48 h) are acceptable and often do not have any demonstrable effect on the abundance or integrity of the parameter being studied 19 . In fact, it is much more important to know how the person died than how long they were dead before the brain was processed. A powerful influence is brain acidosis, a biochemical correlate of pre mortem features such as coma or hypoxia. Brain or cerebrospinal fluid pH strongly predicts the abundance of many mRNAs and other gene products 20 * 21 , such that knowledge of pH and matching between comparison groups should become a prerequisite for quantitative human brain neurochemistry. As an example, studies of P-amyloid precursor protein (|3APP) expression in Alzheimer's disease have been notoriously inconsistent, probably because the mRNA is vulnerable to pre mortem events 22 ' 23 and this had not been controlled for in earlier studies. Conversely, mRNA changes have recently been described in schizophrenia 24 and Parkinson's disease 25 which take brain pH into account. They may, therefore, be interpreted with more confidence as diseaseassociated findings.
Many other peri-mortem confounders can affect neurochemistry. The importance of standardised protocols for brain collection and processing is apparent and is recognised in most brain banks 26 . Regarding processing, it is noteworthy that conventional formalin fixed, wax embedded material is suitable for a surprising range of the techniques listed in Table 1 , including extraction of nucleic acids. A recently discovered trick is to microwave the tissue to enhance the success of imrnunocytochemical and in situ hybridization methods 27 . In this and other ways, even archival brain material can be retrieved for molecular and imrnunochemical approaches.
The major peri-mortem factors are summarised in Table 2 , with straightforward ways to help overcome them presented in Table 3 . It is uncertain how much of the residual neurochemical variance between Table 2 Confounding 
Examples of recent advances from post mortem schizophrenia research

Dopamine D 4 receptors
Neurochemical studies of schizophrenia continue to be extremely diverse, reflecting the different hypotheses which abound concerning the nature of the abnormalities characterising the disease. However, the major focus remains neuroreceptors implicated by virtue of a belief that they or their associated transmitter systems are involved in the disease pathophysiology, or, more speculatively, as candidate genes. 36 , and its polymorphisms have proved to be of less significance for the actions of clozapine than anticipated 29 ' 37 ' 38 .
5-HTreceptors
Interest in the 5-HT system in schizophrenia has been spurred on by an increasing body of post mortem data 39 , by evidence that 5-HT receptors may be relevant (perhaps more so than the D 4 receptor) to the mechanism of action of atypical antipsychotics 40 ' 41 , and by genetic data 42 . There are two changes in 5-HT receptor expression which seem to characterise the disease: an increase in 5-HT 1A receptor binding sites in frontal cortex which is not accompanied by increased 5-HT 1A receptor mRNA 43 ; and a loss of cortical 5-HT 2A receptors, which is paralleled by a loss of its mRNA 24 ' 43 . These data illustrate the value of combining the study of a receptor (or other protein) with that of its mRNA. For example, if the abundance of a receptor changes but its mRNA doesn't, altered translational or post-translational processes may be invoked, whereas if both receptor and mRNA change in parallel, transcriptional regulation is most likely. (The third possibility, that the abundance of an mRNA changes but not that of the receptor, is harder to interpret; it suggests an alteration in gene expression regulation which is compensated for at the protein level.) Correlation of findings from each approach with analysis of receptor polymorphisms 24 is a novel extension of post mortem work which will become of increasing importance as efforts begin to be made to understand relationships between genotype, phenotype and treatment response 41 ; one illustration is in Alzheimer's disease, where allelic variation in the apolipoprotein E (apoE) gene affects apoE expression 44 and the pathological features of the disease 45 , in addition to its major influence on disease risk and age of onset 46 .
Synoptic pathology
The discovery that schizophrenia is associated with structural brain abnormalities is at the same time both a small step and a giant leap.
Resolution of this long-standing controversy has eventually come about through a combination of imaging and post mortem studies 47 -48 . However, the location and nature of the pathological changes remain uncertain 49 and it is now necessary to identify their histological, neuronal, and molecular characteristics if there is to be a convergence of structural, biochemical and genetic aspects of the disease.
One component of the neuropathology of schizophrenia appears to be synaptic alterations. Changes in the density, number, type, or structure of synapses is important both for neuronal plasticity and as a substrate of brain disorders, including Alzheimer's disease and temporal lobe epilepsy. Synaptic alterations have often been proposed to occur in schizophrenia as part of the neurodevelopmental anomaly which putatively underlies the disease. However, testing of the prediction is difficult since it has traditionally required electron microscopic investigation, which is severely limited both by the availability of suitable tissue and by the resources needed to carry out a study of adequate size.
Recently, detection of specific presynaptic proteins, such as synaptophysin, has been shown to be a suitable marker of synaptic terminals and, moreover, their abundance can be used as a proxy measure of synaptic density 50 . Changes in distribution and level of synaptophysin, measured either immunocytochemically or by immunoblotting, have thereby been used to detect synaptic alterations in aging, degenerative disorders and after experimental manipulations 51 .
We have used synaptophysin to address the question of synaptic alterations in schizophrenia. Having first characterised the vulnerability of synaptophysin and its mRNA to peri-mortem factors 52 , we compared hippocampal synaptophysin gene expression in schizophrenics and matched controls. We found a significant loss of synaptophysin mRNA in most subfields in the cases, but only a non-significant trend for the protein, measured in terms of tissue immunoreactivity after immunocytochemical detection 13 . However, the latter method has limitations as a quantitative technique so we turned to immunoautoradiography, a combination of immunocytochemistry and autoradiography and which has advantages in this regard. We were thereby able to demonstrate a loss of synaptophysin in schizophrenia 53 , supporting our mRNA data. Antipsychotics (haloperidol or clozapine) do not alter hippocampal synaptophysin expression in rats ( 13 and unpublished observations), reducing the likelihood that the changes are secondary to medication.
The abnormalities in synaptic density and/or plasticity implied by the synaptophysin data is supported by several other recent findings in the medial temporal lobe in schizophrenia. These include reduced subicular neuronal size 54 , decreased density of staining of the mossy fibre pathway from dentate gyrus to Ammon's horn 55 , a loss of embryonic nerve cell adhesion molecule 56 and differences in hippocampal cytoarchitecture 57 . However, other synaptic protein data are more equivocal 58 , indicating the need for further studies. Synaptophysin is thought to label all synaptic terminals and it remains to be seen whether phenotypically-defined subpopulations of neurons or synapses are differentially affected in schizophrenia; this question could be approached either by the use of synaptic proteins limited to certain synaptic types 59 ' 60 or by doublelabelling techniques.
The synaptophysin work illustrates several of the recent themes of post mortem research mentioned above: more careful attention to confounders such as peri-mortem events and medication, the use of new tools (detection of synaptic protein gene products), the use of several complementary methods to address a single question, and the application of image analysis for quantitation.
Summary and future directions
Conceptual and practical limitations of post mortem research will always remain. These are particularly pertinent for schizophrenia and other diseases whose neurobiological signature is faint, and for which the question of disease heterogeneity and the validity of the syndromal category itself remains unanswered 61 . However, the influence of the limitations can be minimised by a combination of good experimental design, continuing technical developments, and increasing integration with in vivo approaches. If these principles are followed, not only are the data more robust, but it becomes possible to develop testable hypotheses as well as merely cataloguing ever more detailed alterations 62 . In this mode, the post mortem approach retains its status as an essential component of biological psychiatry, and one which is complementary to, not replaced by, developments in functional imaging, peripheral markers, or molecular genetics.
